ACSL6 is more highly expressed in NASH than HOC, although it has previously been reported in several cell lines, including the hepatoma cell line HepG2, not to be associated with ferroptosis (67). This evidence concerns the gene ACSL6 and metabolic dysfunction-associated steatohepatitis.